L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum (Q48687516)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2014

Language	Label	Description	Also known as
English	L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum	scientific article published on 26 June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yong Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

Hui Sheng Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

Tao Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

Chen Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

Jian Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

publication date

26 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

92

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

12

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

1733-1745

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Functional changes of the basal ganglia circuitry in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Pathophysiology of parkinsonism

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

The role of the locus coeruleus in the development of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Molecular mechanisms of L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Norepinephrine: The redheaded stepchild of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: a microdialysis study

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Regional distribution of dopamine beta-hydroxylase and monoamine oxidase in the brains of rats exposed to manganese

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-B-hydroxylase as a marker

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: An in situ hybridization study

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23439

21 January 2018

Identifiers

10.1002/JNR.23439

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/24975553

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48687516&oldid=2206815565"